Navigation Links
The Leukemia & Lymphoma Society and the Nation's Triathlon Announce New Partnership
Date:2/19/2008

The first triathlon to benefit blood cancer research to take place Sept.

14, 2008 in Washington, DC

WHITE PLAINS, N.Y., Feb. 19 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) and the Nation's Triathlon(R) today announced a new partnership that will leverage the surging number of triathletes and popularity of the sport to help raise money for blood cancer research. Utilizing LLS's world-famous Team In Training(R) (TNT) endurance sports training program -- which has raised $850 million for cancer research and trained 360,000 people since its inception in 1988 -- the newly branded Nation's Triathlon To Benefit The Leukemia & Lymphoma Society is the first triathlon in the nation dedicated to raising money to help cure blood cancers.

This year's race, scheduled for Sunday, Sept. 14, 2008, is projected to raise more than $3.3 million to support LLS's research, patient education and support initiatives.

"LLS's goal is to do for triathlons what we've done for marathons over the past 20 years," said Nancy Klein, senior vice president, LLS Marketing Communications, speaking of the fundraising program that grew from 40 runners to more than 360,000 in 20 years. "LLS is once again getting ahead of the wave, and we're ready to put the muscle behind this campaign. More importantly, triathletes are ready for the spaces to open to them."

The new partnership comes at a time when the popularity of triathlons is growing exponentially, outpacing the capacity of existing triathlons. For example, TNT's triathlon program has grown dramatically since it was first introduced in 1999; last year alone, TNT trained more than 5,800 triathletes. Nation's Triathlon, launched two years ago, has grown significantly as well, from nearly 500 participants in its first year to a projected 3,500 participants this year. Set amid Washington, DC's magnificent vistas and plentiful parkland, the race can continue to grow, with the support of TNT, to become the largest triathlon in the world. The capacity will not only widen the field for triathletes, but will contribute significantly to boosting LLS's revenue for research and other patient-focused programs.

"We are proud to forge a partnership with LLS," said Charles Brodsky, the triathlon's founder. "The money they have raised over the years has contributed significantly to research that is helping bring us closer to a cure every day. To support such a worthy cause, while also giving people the opportunity to participate in a sport that promotes fitness and good health, is an exciting opportunity. We look forward to growing our triathlon program and providing competitors with a world-class event in a world- class city."

About Team In Training

Team In Training, the world's largest endurance sports training program, succeeds by harnessing the dedication of people who cling strongest to its goals and by providing four to five months of personal training, making triathlon doable even for first-time athletes. Husbands, wives, parents, children and friends of cancer patients -- sensing the finish line is just ahead -- raise more than $100 million each year, supporting researchers and patients. The financial support has created equally dramatic improvements in the way the blood cancers leukemia, lymphoma and myeloma are diagnosed and treated -- from new drugs that can cure to improved therapies that make treatment less harsh on the body. For additional information, call (800) 482- TEAM or visit http://www.teamintraining.org.

About Nation's Triathlon

Nation's Triathlon is the premiere Olympic distance triathlon in the United States. Set against the magnificent and patriotic setting of the nation's capital and its monuments, participants in the Nation's Triathlon will swim 1.5K in the Potomac River, a course that will take them under the Memorial Bridge, bike 40K through downtown DC, out onto Clara Barton Parkway and Rock Creek Park, and run 10K through downtown DC, past the White House, Washington Monument and the National Mall, finishing on the plaza of the Navy Memorial on Pennsylvania Avenue. Major sponsors include: UnitedHealthcare - Official Healthcare Provider and Sponsor of The UnitedHealthcare Sports & Fitness Expo; Timex -- Official Timekeeper for The Timex Timing Zone; and JetBlue -- Official Airline and Sponsor for The JetBlue Airways Finish Festival. Additional sponsors include: City Sports, Crocs, Coke Zero, Dasani, and Race Train Fitness.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society, headquartered in White Plains, NY, with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $550 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 5.1 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit http://www.LLS.org or call the LLS's Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

Contact: Andrea Greif, 914.821.8958

Andrea.greif@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
2. Study finds heart failure is rare among leukemia patients on imatinib
3. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Novel strategy under study for aggressive leukemia
7. Drug has ability to cure type of leukemia
8. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
9. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
10. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
11. St. Jude Finds Anti-Leukemia Drug Increases Patient Fatigue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announced today that it has raised $6.0 million in an initial round of ... Health’s conviction that patients and their caregivers can receive far better care through ...
(Date:12/2/2016)... Grants Pass, OR (PRWEB) , ... December 02, ... ... Daryl Wein, Medical Technologist/Clinical Laboratory Scientist & Author of Type 2 Diabetes: The ... and host of The Sharon Kleyne Hour Power of Water, Global Climate Change ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... offer a comprehensive in-house dental plan for all patients. Understanding that budget can ... that gives patients a number of perks, including discounts on many valuable dental ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For Discovery, a nationally ... of a new eating disorder treatment center location in Palm Beach Gardens, Florida.  The ... adolescents, both males and females ages 10 and older with eating disorders, including ...
(Date:11/30/2016)... ... November 30, 2016 , ... The ... stylish design wanted by today’s consumers at an affordable price, is now available ... the new watch is “a game changer” when it comes to the smartwatch. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec 1, 2016 Research ... "Drug Delivery in Cancer - Technologies, Markets and Companies" ... , ... challenge in management of cancer The market value of ... Cancer market estimates from 2015-2025 are given according to organs involved ...
(Date:12/2/2016)... pleased to announce that 12 scientific abstracts have been accepted ... Epilepsy Society (AES) Annual Meeting, which takes place from 2-6 ... Data being presented include posters further ... (lacosamide) CV and BRIVIACT ® (brivaracetam) CV. 2,3,4,6,8 ... the union of epilepsy care and antiepileptic drugs in the ...
(Date:11/30/2016)... -- Research and Markets has announced the addition of ... MedCore" report to their offering. ... , The cerebrospinal fluid (CSF) ... individuals, it is circulated though the brain and its ventricles, the spine ... CSF surrounding the brain changes significantly. As a ...
Breaking Medicine Technology: